Pharma Stocks News
Dr Reddy’s pins hopes on semaglutide, but timely approvals hold the key
The company’s exports plan faces delays in approvals, with the pharmaceutical drugs directorate of Canada issuing it a notice of non-compliance in response to its application.
2 min read4 Dec 2025Wockhardt share price jumps over 19% after US FDA accepts new drug application for Zaynich
Wockhardt's shares jumped 19.3% to ₹1,473 following the US FDA's acceptance of its antibiotic drug Zaynich's New Drug Application. The pharma shares have remained under pressure since hitting a one-year high in July 2025 and have so far lost 22% of their value.
2 min read1 Dec 2025Small-cap pharma stock jumps over 10% despite dip in key indices of Indian stock market
Balaxi Pharmaceuticals' shares rose 10% to ₹39.5 despite broader market declines, but remain down 11.50% in November. The stock has faced selling pressure since May 2024, losing 47.42% this year and 17% last year, significantly impacting retail investors.
1 min read21 Nov 2025Mutual funds lose over ₹1,500 crore in this pharma stock as it crashes 28% in 12 sessions
Cohance Lifesciences share price fell another 2.2% on Friday, marking a 12-session losing streak and a total decline of 28.4%. The downturn began after the resignation of Managing Director V. Prasada Raju and poor financial performance in Q2, including a 52% drop in net profit.
3 min read14 Nov 2025Investors bet weight-loss drugs will fatten contract manufacturers’ profits first
Shares of Indian contract development and manufacturing companies that are already able to manufacture blockbuster drugs such as semaglutide have jumped 7-141% over the past year, while those of drug formulators have returned -12% to 1%. What explains the stark difference in sentiment?
7 min read16 Oct 2025Mint Explainer: The US Biosecure Act is back. How will Indian contract manufacturers benefit?
Shares of companies such as Divi's Laboratories, Syngene, Laurus Labs, Piramal Pharma and Blue Jet Healthcare surged up to 5% on Friday after the bill, which had been blocked in 2024, was approved by the US Senate. What's in store for these companies if it becomes law?
4 min read13 Oct 2025Divi’s Laboratories, Piramal Pharma to Laurus Labs: Why are pharma stocks skyrocketing today?
Divi’s Laboratories, Piramal Pharma, Wockhardt, Cipla, Laurus Labs, Aurobindo Pharma, Glenmark Pharmaceuticals, Dr Reddy’s Laboratories were among the top gainers in the Nifty Pharma index.
1 min read10 Oct 2025Top Gainers & Losers on Oct 06: Aditya Birla Lifestyle Brands, BSE, Paytm, Nykaa, Ather Energy among top gainers
Indian frontline indices gained nearly 1% on October 6, with the Nifty 50 closing at 25,077 and the Sensex at 81,709. IT, healthcare, and private banks led the rally, while Nifty Media lagged. Aditya Birla Lifestyle surged 8.1% following a block deal.
3 min read6 Oct 2025IT, pharma, FMCG market-cap share hits 14-year low amid Trump tariffs, H1B visa fee hike; Cyclicals’ profit pool expands
The profit pool share of defensives has dwindled to 16% from nearly 40% in FY21 and is expected to slide towards its historical low of around 14% over the next two years. Their market-cap share has already fallen to ~20% — the lowest since 2011 — from a peak of 30% in 2020.
2 min read6 Oct 2025Can Trump's $100,000 H-1B visa fee hike boost local hiring? Geojit's Vinod Nair explains how
Vinod Nair, Head of Research, Geojit Financial Services, sheds light on how Donald Trump's $100,000 H-1B visa fee hike is expected to impact Indian IT companies in the short term, prompting a shift toward increased local hiring.
3 min read5 Oct 2025Popular Topics
Budget
The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.